Stock Events

Stock Events

BeyondSpring 

$0.7429
26
+$0.02+3.45% 08:00 Today

Statistics

Day High
0.717
Day Low
0.717
52W High
2.44
52W Low
0.6699
Volume
1,000
Avg. Volume
-
Mkt Cap
29.53M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14AugExpected
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.05
0
0.06
0.11
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-1.01MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BYSI. It's not an investment recommendation.
Apple
6
AAPL
Microsoft
6
MSFT
Tesla
6
TSLA
Amazon
6
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap335.14B
Merck & Co., Inc. is a global healthcare company that develops medications in oncology, among other areas, directly competing with BeyondSpring's cancer treatment pipeline.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol-Myers Squibb operates in the biopharmaceutical industry focusing on cancer treatments, making it a direct competitor to BeyondSpring's oncology-focused therapies.
Pfizer
PFE
Mkt Cap152.69B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including cancer drugs, competing with BeyondSpring's offerings.
AMGEN
AMGN
Mkt Cap224.63B
Amgen Inc. focuses on human therapeutics, including oncology/hematology, which competes with BeyondSpring's cancer treatment developments.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences, Inc. is a biopharmaceutical company that develops and markets therapies in areas including oncology, competing with BeyondSpring's cancer drugs.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company with a strong emphasis on oncology, making it a competitor to BeyondSpring.
Novartis
NVS
Mkt Cap286.78B
Novartis AG focuses on patented medicines across multiple segments, including oncology, directly competing with BeyondSpring's cancer therapies.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG specializes in pharmaceuticals and diagnostics. Its strong focus on oncology research and treatments makes it a competitor to BeyondSpring.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, with its pharmaceutical segment competing in oncology.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals, Inc. is known for its innovation in biotechnology, including oncology, competing with BeyondSpring's research and drug development.

About

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
Show more...
CEO
Qiu Min
Employees
44
Country
United States
ISIN
KYG108301006

Listings

XNAS
US
BYSI
BOATS
BOATS
BYSI.BOATS

0 Comments

Share your thoughts

FAQ

What is BeyondSpring stock price today?▼
The current price of BYSI is $0.74 USD — it has increased by +3.45% in the past 24 hours. Watch BeyondSpring stock price performance more closely on the chart.
What is BeyondSpring stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange BeyondSpring stocks are traded under the ticker BYSI.
Is BeyondSpring stock price growing?▼
BYSI stock has fallen by -3.22% compared to the previous week, the month change is a -44.33% fall, over the last year BeyondSpring has showed a -58.97% decrease.
What is BeyondSpring market cap?▼
Today BeyondSpring has the market capitalization of 29.53M
When is the next BeyondSpring earnings date?▼
BeyondSpring is going to release the next earnings report on December 17, 2026.
What is BeyondSpring revenue for the last year?▼
BeyondSpring revenue for the last year amounts to 0 USD.
What is BeyondSpring net income for the last year?▼
BYSI net income for the last year is -1.01M USD.
How many employees does BeyondSpring have?▼
As of August 19, 2026, the company has 44 employees.
In which sector is BeyondSpring located?▼
BeyondSpring operates in the Health & Wellness sector.
When did BeyondSpring complete a stock split?▼
BeyondSpring has not had any recent stock splits.
Where is BeyondSpring headquartered?▼
BeyondSpring is headquartered in FLORHAM PARK, United States.